Trial Profile
Enhancing slow wave sleep with sodium oxybate to reduce the behavioral and physiological impact of sleep loss
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2008
Price :
$35
*
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Sleep disorders
- Focus Therapeutic Use
- 29 Sep 2008 Actual end date changed from 1 May 2008 to 1 May 2008 as reported by ClinicalTrials.gov.
- 29 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Aug 2007 New trial record.